{"id":"NCT01332188","sponsor":"Aciex Therapeutics, Inc.","briefTitle":"Efficacy of AC-170 for the Treatment of Allergic Conjunctivitis in the Conjunctival Allergen Challenge (CAC) Model","officialTitle":"A Single Center, Double-Masked, Randomized, Vehicle-Controlled, Parallel-Group Study Evaluating the Efficacy of Three Different Concentrations of Cetirizine (0.05%, 0.1%, and 0.24%) Ophthalmic Solution Versus Vehicle in the Treatment of Allergic Conjunctivitis in the Conjunctival Allergen Challenge Model (CAC)","status":"COMPLETED","phase":"PHASE2","dates":{"start":"2011-04","primaryCompletion":"2011-06","completion":"2011-10","firstPosted":"2011-04-11","resultsPosted":"2017-08-30","lastUpdate":"2017-08-30"},"enrollment":101,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Allergic Conjunctivitis"],"interventions":[{"type":"DRUG","name":"AC-170 0.05%","otherNames":[]},{"type":"DRUG","name":"AC-170 0.1%","otherNames":[]},{"type":"DRUG","name":"AC-170 0.24%","otherNames":[]},{"type":"DRUG","name":"AC-170 0%","otherNames":[]}],"arms":[{"label":"AC-170 0.05%","type":"EXPERIMENTAL"},{"label":"AC-170 0.1%","type":"EXPERIMENTAL"},{"label":"AC-170 0.24%","type":"EXPERIMENTAL"},{"label":"AC-170 0%","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to evaluate the efficacy of different concentrations of AC-170 compared to vehicle in the prevention of the signs and symptoms of allergic conjunctivitis in the conjunctival allergen challenge (CAC) Model.","primaryOutcome":{"measure":"Ocular Itching at Duration of Action (16 Hours Post-dose)","timeFrame":"3, 5, 7 minutes post-CAC","effectByArm":[{"arm":"AC-170 0.05%","deltaMin":1.91,"sd":0.924},{"arm":"AC-170 0.1%","deltaMin":2,"sd":0.771},{"arm":"AC-170 0.24%","deltaMin":1.65,"sd":0.963},{"arm":"AC-170 0%","deltaMin":2.48,"sd":0.54}],"pValues":[]},"eligibility":{"minAge":"10 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":1,"exclusionCount":3},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":25},"commonTop":["Visual acuity reducsed","Photophobia","Petechiae","Dermatitis contact","Back pain"]}}